WMSA
RCKT icon

Weiss Multi-Strategy Advisers’s Rocket Pharmaceuticals RCKT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,075
Closed -$329K – 775
2021
Q4 		$329K Sell
15,075
-1,656
-10% -$45.2K 0.01% 582
2021
Q3 		$500K Sell
16,731
-8,217
-33% -$299K 0.01% 559
2021
Q2 		$1.1M Buy
24,948
+894
+4% +$38.8K 0.02% 478
2021
Q1 		$1.07M Buy
24,054
+12,554
+109% +$689K 0.02% 471
2020
Q4 		$631K Sell
11,500
-8,627
-43% -$314K 0.01% 538
2020
Q3 		$460K Sell
20,127
-3,897
-16% -$96K 0.01% 484
2020
Q2 		$503K Sell
24,024
-147
-0.6% -$2.65K 0.01% 467
2020
Q1 		$337K Buy
24,171
+4,171
+21% +$82.6K 0.01% 366
2019
Q4 		$455K Hold
20,000
– – 0.01% 541
2019
Q3 		$233K Buy
20,000
+3,000
+18% +$37.2K ﹤0.01% 539
2019
Q2 		$255K Buy
17,000
+4,500
+36% +$78.5K 0.01% 460
2019
Q1 		$219K Sell
12,500
-1,500
-11% -$23.7K 0.01% 477
2018
Q4 		$207K Buy
+14,000
New +$232K 0.01% 411

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Weiss Multi-Strategy Advisers's RCKT Position: Q1 2022 in Review

Weiss Multi-Strategy Advisers sold out of Rocket Pharmaceuticals (RCKT) in Q1 2022, closing a stake of 15,075 shares — an estimated $329K sold.

Weiss Multi-Strategy Advisers first reported a position in RCKT in Q4 2018 and held it in 13 quarters. The position peaked at $1.1M in Q2 2021. 149 funds tracked by Wall St. Rank hold RCKT as of Q1 2022.

  • Weiss Multi-Strategy Advisers reported no remaining Rocket Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 15,075 Rocket Pharmaceuticals shares in Q1 2022, an estimated $329K.
  • Weiss Multi-Strategy Advisers first reported a position in Rocket Pharmaceuticals in Q4 2018 and held it in 13 quarters.
  • Weiss Multi-Strategy Advisers's Rocket Pharmaceuticals position peaked at $1.1M in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2022, filed 16 May 2022.